New data in Brazil shows a disappointing 50.4% efficiency for the CoronaVac vaccine in China
By Eduardo SimõesSAO PAULO (Reuters) – A coronavirus vaccine developed by China’s Sinovac Biotech was only 50.4% effective in preventing symptomatic infections in a Brazilian trial, res…
